ASAP Summit and Conference participants spend a lot of time sitting, listening, and absorbing the most cutting-edge information in the industry. Now it’s your turn to be a speaker, guide, and thought provoker in a new session format at this year’s ASAP BioPharma Conference Sept. 7-9, “New Faces, Unexpected Places in Partnering: The Foresight to Lead, the Foundation to Succeed,” at the Revere Hotel Boston Common, Boston. The Aquarium session encourages attendees to dive in and wrestle with the hot topics of the day in a creative, ASAP-designed version of the “fishbowl” learning activity. Moderated by Jan Twombly, CSAP, president of The Rhythm of Business, the session will start with a lively exchange on key topics from several experts in the field of alliance management as the audience peers into the tank. There will be three 25-minute rounds during the session, each with a separate topic. Participants will be allowed to “tap in” and move the conversation in new directions. When someone comes onto the stage, one person must exit.
“We’re not sticking to a script; each of these topic discussion could branch off,” explains Ann Johnson, ASAP’s content manager, who has developed the concept as an innovation ASAP programming. “That’s the beauty of nontraditional session structure like this: It allows for free-space that often results in exploring topics in real and meaningful ways … through many different lenses. It encourages engagement, peer-to-peer sharing, and participation, which is what our members want. There are no right answers to these topics, and in fact we want to hear diverse viewpoints,” Johnson adds. “This is a way to hear from the voices we often don’t hear from.”
It’s an opportunity to become a member of the “school” in a fast-paced, collective swim that is geared to leave participants with a more creative and innovative perspective on the potential for change in alliance management. The following preselected topics are designed to jumpstart the conversation:
Topic #1: Lead, Follow, or Get Out of the Way
True or False: The alliance management profession in biopharma has the respect, skills, and ability to lead companies into partnering with different types of partners, across industries, and in new models.
Topic #2: Handle with Care: Managing the C-Suite
How do you ensure executive leadership (C-Suite) is appropriately involved in an alliance, without giving them a seat at the table, especially when the alliance is between a small, innovative company and big pharma?
Topic #3: Breadth or Depth – What Does it Take to Succeed?
Which qualities will be more highly valued in alliance managers as the industry adapts to digitization, outcomes based pricing, and an increasing number and variety of partnerships: broad business and technical skills and experience or deep pharmaceutical industry knowledge and experience?
As the conversation evolves, participants will then get a chance to bump the following thought leaders and senior-level partnering executives off the stage:
- Jeremy Ahouse, CSAP, PhD, Executive Director Alliance Management, Celgene
- Harm-Jan Borgeld, CSAP, PhD, Head Alliance Management, Merck Serono
- David Burnham, Senior Vice President Strategic Alliance Management, INC Research
- Mark Coflin, CSAP, Senior Director Alliance Management Global BD&L, Baxalta US Inc.
- Cathy Connelly, CA-AM, Head, Alliance Management, Sanofi Genzyme
- Andy Hull, CA-AM, Vice President, Global Alliances, Takeda Pharmaceuticals
- Katherine Kendrick, CA-AM; Director of Alliance Management, Elanco, Eli Lilly and Company
- Brooke A. Paige, CSAP, Staff Vice President, Strategic Initiatives, HealthCore, Inc.
- Petra Sansom, Sr. Director, Alliance Management, Vertex Pharmaceuticals
- Mary Jo Struttmann, CA-AM; Executive Director, Global Alliance Management, Astellas Pharma Inc.
- Michael Sumpter, Head of Alliance Management, Servier Monde
- David S. Thompson, CA-AM, Chief Alliance Officer, Eli Lilly and Company
- Steve Twait, CSAP, VP, Alliance and Integration Management, AstraZeneca
Photo credit: MB Photo Credit: W. Chappell